ATE484284T1 - Pharmazeutische kombinationen mit lamivudin, stavudin und nevirapin - Google Patents

Pharmazeutische kombinationen mit lamivudin, stavudin und nevirapin

Info

Publication number
ATE484284T1
ATE484284T1 AT06779251T AT06779251T ATE484284T1 AT E484284 T1 ATE484284 T1 AT E484284T1 AT 06779251 T AT06779251 T AT 06779251T AT 06779251 T AT06779251 T AT 06779251T AT E484284 T1 ATE484284 T1 AT E484284T1
Authority
AT
Austria
Prior art keywords
stavudine
nevirapine
lamivudine
pharmaceutical combinations
pharmaceutical
Prior art date
Application number
AT06779251T
Other languages
English (en)
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Application granted granted Critical
Publication of ATE484284T1 publication Critical patent/ATE484284T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT06779251T 2005-08-31 2006-08-31 Pharmazeutische kombinationen mit lamivudin, stavudin und nevirapin ATE484284T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1057MU2005 2005-08-31
PCT/GB2006/003229 WO2007026156A1 (en) 2005-08-31 2006-08-31 Pharmaceutical combinations containing lamivudine, stavudine and nevirapine

Publications (1)

Publication Number Publication Date
ATE484284T1 true ATE484284T1 (de) 2010-10-15

Family

ID=37442043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06779251T ATE484284T1 (de) 2005-08-31 2006-08-31 Pharmazeutische kombinationen mit lamivudin, stavudin und nevirapin

Country Status (14)

Country Link
US (1) US20080241265A1 (de)
EP (1) EP1931358B1 (de)
KR (1) KR20080053317A (de)
AP (1) AP2008004389A0 (de)
AT (1) ATE484284T1 (de)
AU (1) AU2006286314A1 (de)
BR (1) BRPI0617074A2 (de)
CA (1) CA2620853A1 (de)
DE (1) DE602006017569D1 (de)
ES (1) ES2352216T3 (de)
MA (1) MA29813B1 (de)
NZ (1) NZ566796A (de)
WO (1) WO2007026156A1 (de)
ZA (1) ZA200802751B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2014140177A (ru) * 2012-03-05 2016-04-27 Сипла Лимитед Фармацевтические антиретровирусные композиции
CN104677786B (zh) * 2015-03-09 2017-07-18 上海理工大学 一种基于双目3d视觉的休止角测量方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5616578A (en) * 1993-08-26 1997-04-01 The Dupont Merck Pharmaceutical Company Method of treating human immunodeficiency virus infection using a cyclic protease inhibitor in combination with a reverse transcriptase inhibitor
PL192361B1 (pl) * 1997-08-25 2006-10-31 Boehringer Ingelheim Pharma Kompozycja farmaceutyczna hemihydratu newirapiny i sposób wytwarzania wodnej zawiesiny hemihydratu newirapiny
DE69916425T2 (de) * 1998-01-16 2005-05-19 Medivir Ab Antivirale mittel
BR0109602A (pt) * 2000-03-30 2004-06-29 Bristol Myers Squibb Co Glóbulos de liberação controlada contendo estavudina
IT1318463B1 (it) * 2000-04-12 2003-08-25 Archimica S P A Ora Clariant L Procedimento per la preparazione di 5'-acetilstavudina.

Also Published As

Publication number Publication date
BRPI0617074A2 (pt) 2011-07-12
EP1931358A1 (de) 2008-06-18
CA2620853A1 (en) 2007-03-08
DE602006017569D1 (de) 2010-11-25
AP2008004389A0 (en) 2008-04-30
NZ566796A (en) 2011-04-29
US20080241265A1 (en) 2008-10-02
ES2352216T3 (es) 2011-02-16
AU2006286314A1 (en) 2007-03-08
WO2007026156A1 (en) 2007-03-08
EP1931358B1 (de) 2010-10-13
KR20080053317A (ko) 2008-06-12
ZA200802751B (en) 2009-07-29
MA29813B1 (fr) 2008-09-01

Similar Documents

Publication Publication Date Title
CY2017029I1 (el) ΑΝΤΙΚΑΡΚΙΝΙΚΟ ΦΑΡΜΑΚΟ ΠΟΥ ΠΕΡΙΕΧΕΙ α,α,α-ΤΡΙΦΘΟΡΟΘΥΜΙΔΙΝΗ ΚΑΙ ΑΝΑΣΤΟΛΕΑ ΦΩΣΦΟΡΥΛΑΣΗΣ ΘΥΜΙΔΙΝΗΣ
EP1992348A4 (de) Pharmazeutische kombination
HUE058876T2 (hu) Anti-GM-CSF antitestek és felhasználásuk
DK1894567T3 (da) Ledsagende farmaceutiske midler og anvendelse deraf
FI20050739A0 (fi) Mikromekaaninen sensori, sensoriryhmä ja menetelmä
DK2051975T3 (da) Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel.
BRPI0818690A2 (pt) Derivados de quinazolinediona, sua preparação e seus usos terapêuticos.
EP1866984A4 (de) Zusammengesetztes material, lichtemittierendes element und lichtemittierende einrichtung
DK3181691T3 (da) Anti-fgf23-antistof og en farmaceutisk sammensætning omfattende samme
ATE552828T1 (de) Arzneiformen mit verbesserten pharmakokinetischen eigenschaften
DE502005004791D1 (de) Messfühler mit Selbsttest
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
DE602005022995D1 (de) Arylsulfone und damit verbundene verwendungen
DK1753725T3 (da) Tetra-hydro-iso-quinolinsulfonamidderivater, fremstilling og terapeutisk anvendelse heraf.
DK1773829T3 (da) Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
FR2891825B1 (fr) Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique
ATE484284T1 (de) Pharmazeutische kombinationen mit lamivudin, stavudin und nevirapin
DE602005012287D1 (de) Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung
ATE371716T1 (de) Tabletten mit verbessertem bruchswiderstand
ATE370218T1 (de) Tabletten mit verbessertem bruchswiderstand
DE602006017975D1 (de) Feste pharmazeutische zusammensetzung mit telithromycin
DE602006018617D1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten
DK1954288T3 (da) Amidin-derivater og anvendelse deraf som lægemiddel
FR2893615B1 (fr) Derives de 3-acylindole, leur preparation et leur application en therapeutique
DK1720557T3 (da) Hurtig-opløselig, smagsmaskeret tablet

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties